Literature DB >> 7314253

Rifampicin induced osteomalacia.

S C Shah, R K Sharma, A R Chitle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7314253     DOI： 10.1016/0041-3879(81)90008-8

Source DB:  PubMed          Journal:  Tubercle        ISSN： 0041-3879


× No keyword cloud information.
  19 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  Resurgence of vitamin D: Old wine in new bottle.

Authors:  Raju Vaishya; Vipul Vijay; Amit Kumar Agarwal; Jabed Jahangir
Journal:  J Clin Orthop Trauma       Date:  2015-03-26

Review 3.  Clinically Relevant Herb-Micronutrient Interactions: When Botanicals, Minerals, and Vitamins Collide.

Authors:  Bill J Gurley; Alyssa Tonsing-Carter; Sheila L Thomas; E Kim Fifer
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

4.  An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

Authors:  Zhican Wang; Yvonne S Lin; Xi Emily Zheng; Tauri Senn; Takanori Hashizume; Michele Scian; Leslie J Dickmann; Sidney D Nelson; Thomas A Baillie; Mary F Hebert; David Blough; Connie L Davis; Kenneth E Thummel
Journal:  Mol Pharmacol       Date:  2011-12-28       Impact factor: 4.436

5.  Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis.

Authors:  M J Brodie; C J Hillyard
Journal:  J R Soc Med       Date:  1982-11       Impact factor: 5.344

Review 6.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 7.  Nuclear receptor PXR, transcriptional circuits and metabolic relevance.

Authors:  Chibueze A Ihunnah; Mengxi Jiang; Wen Xie
Journal:  Biochim Biophys Acta       Date:  2011-02-02

8.  Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation.

Authors:  Yoshihiro Konno; Susumu Kodama; Rick Moore; Nobuhiro Kamiya; Masahiko Negishi
Journal:  Mol Pharmacol       Date:  2008-11-03       Impact factor: 4.436

9.  Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.

Authors:  Zhican Wang; Yvonne S Lin; Leslie J Dickmann; Emma-Jane Poulton; David L Eaton; Johanna W Lampe; Danny D Shen; Connie L Davis; Margaret C Shuhart; Kenneth E Thummel
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

Review 10.  Interplay between vitamin D and the drug metabolizing enzyme CYP3A4.

Authors:  Zhican Wang; Erin G Schuetz; Yang Xu; Kenneth E Thummel
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-15       Impact factor: 4.292
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.